Trial intelligence / Profile preview

GYS granules for premenstrual syndrome (liver qi stagnation) dose‑finding

CTR20150852Phase 2Active

Sponsor
Hefei Jingfang Pharmaceutical Technology Development
Start
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of GYS in premenstrual syndrome (PMS), sponsored by Hefei Jingfang Pharmaceutical Technology Development. Started Jan 2016; status: active.

02

Drugs

GYS
03

Conditions

premenstrual syndrome (PMS)

Beyond the preview

Go deeper on CTR20150852.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150852.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call